Lorad MultiCare Mammography

The Lorad MultiCare is a dedicated mammography system developed for advanced breast imaging, with a specific focus on stereotactic biopsy procedures. Designed by Hologic, a leader in women’s health technologies, this system is known for its precision, efficiency, and patient-centric approach, particularly in diagnostic and interventional breast imaging.

Key Features

1. Stereotactic Breast Biopsy Capability:
   The Lorad MultiCare system is widely used for performing minimally invasive breast biopsies. Its stereotactic technology allows precise targeting of abnormalities detected on mammograms, enabling tissue sampling with high accuracy.

2. Exceptional Imaging Quality:
   With advanced imaging technology, the system produces high-resolution images, making it easier for radiologists to identify and assess subtle breast tissue changes.

3. Dual-Axis Approach:
   The MultiCare system’s dual-axis capability minimises patient repositioning during biopsy procedures, reducing procedure time while maintaining accuracy.

4. Patient Comfort:
   The system is ergonomically designed, offering features like adjustable positioning and padded surfaces to enhance patient comfort during both diagnostic imaging and biopsy procedures.

5. Compact Design:
   Its compact design allows it to fit into small clinical spaces without compromising functionality, making it ideal for both outpatient clinics and larger healthcare facilities.

6. Ease of Use for Clinicians:
   The intuitive interface and streamlined workflow simplify operation for radiologists and technologists, improving efficiency during procedures.

7. Low Radiation Dose:
   Like other modern mammography systems, the Lorad MultiCare prioritises patient safety by operating with low radiation doses while maintaining high imaging quality.

Application

• Stereotactic Biopsies: Enables precise sampling of suspicious breast lesions identified during routine mammography or ultrasound.
• Diagnostic Mammography: Provides detailed imaging for patients with abnormal screening results.
• Microcalcification Evaluation: Effective in assessing areas of concern, such as clusters of microcalcifications that could indicate early breast cancer.